QSI
HealthcareQuantum-Si incorporated
$1.26
+$0.10 (+8.62%)
Jan 5, 2026
Price History (1Y)
Analysis
Quantum-Si incorporated is a company operating in the healthcare sector, specifically within the medical devices industry. As of available data, it has a market capitalization of $271.52 million, revenue of $3.18 million (TTM), and employs 149 individuals. From a financial perspective, Quantum-Si recorded negative net income (TTM) of $116,849,000, with an EBITDA loss of $102,356,000. The company's free cash flow was -$49,920,376. Its gross margin stood at 51.7%, while operating and profit margins were significantly lower at -4419.6% and 0.0%, respectively. Return on Equity (ROE) and Return on Assets (ROA) were also negative at -52.4% and -26.8%, respectively. The company had a debt-to-equity ratio of 1.96, with cash reserves amounting to $225.84 million and outstanding debt of $4.61 million. Quantum-Si's valuation metrics include a forward P/E ratio of -3.07 and an EV/EBITDA ratio of -0.28. The company's revenue growth over the past year was -29.9%, while its 52-week high and low were $3.96 and $0.95, respectively. The stock had a beta value of 3.03.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Quantum-Si incorporated
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Visit website →Key Statistics
- Market Cap
- $271.52M
- P/E Ratio
- N/A
- 52-Week High
- $3.96
- 52-Week Low
- $0.95
- Avg Volume
- 9.55M
- Beta
- 3.03
Company Info
- Industry
- Medical Devices
- Exchange
- NGM
- Country
- United States
- Employees
- 149